Skip to content

PSX Pharmaceuticals

FEROZ Ferozsons Laboratories Limited

Latest results: FY2026 · Jun 2026

FY2026 revenue Rs 24.0 bn (+27.0%), profit Rs 978.6 mn (+26.0%). Dividend paid 3 years in a row.

Last close · 13 Nov 2026

Rs 362.49 ▼ 5.47 (-1.49%)

▼ 8.7% 1 year

15 Oct 22 Oct 28 Oct 3 Nov 11 Nov Jun Jul Aug Sep Oct Dec Feb May Jul Oct 2022 2023 2024 2025 2026
293.0152-week range475.00
Market cap
Rs 15.8 bn
P/E
16.1×
FY2026
Sector 12.6× · higher
P/B
1.19×
FY2026
Sector 3.11× · lower
Dividend yield
1.5%
FY2026
Payers 4.7% · lower
ROE
7.6%
FY2026
Sector 21.7% · lower
EPS
Rs 22.51
FY2026
Book value / share
Rs 304.56
FY2026

Fundamentals

FEROZ at a glance

Revenue · FY2026

Rs 24.0 bn

▲ 27.0% year on year

Profit attributable to shareholders · FY2026

Rs 978.6 mn

▲ 26.0% year on year

EPS – basic (Rs) · FY2026

Rs 22.51

▲ 26.0% year on year

Dividend per share (Rs) · FY2026

Rs 5.50

▲ 37.5% year on year

Net margin · FY2026

5.1%

+0.2 pts year on year

Debt to equity · FY2026

27.3%

-2.4 pts year on year

Price performance

FEROZ returns

Close Rs 362.49
13 Nov 2026

Period Return Rs
MTD +3.9% −3.0 pts vs KSE +13.46
3M −3.3% −2.0 pts vs KSE −12.20
6M −3.9% −10.1 pts vs KSE −14.67
YTD −3.5% −5.7 pts vs KSE −13.25
FYTD −10.1% −8.8 pts vs KSE −40.69
1Y −8.7% −19.4 pts vs KSE −34.50
Long term
3Y +82.1% +22.1% a year −132.6 pts vs KSE +163.38
5Y +15.8% +3.0% a year −273.0 pts vs KSE +49.58

Price return from the last close before each period; the fiscal year ends 30 June. Dividends are not included.

Ferozsons Laboratories Limited in brief

Ferozsons Laboratories Limited (FEROZ) reported revenue of Rs 24.0 bn for FY2026 (Jul 2025 – Jun 2026), up 27.0% from FY2025.

Profit attributable to shareholders was Rs 978.6 mn (EPS Rs 22.51), up 26.0%, a net margin of 5.1%.

It declared a dividend of Rs 5.50 per share for FY2026 and has paid a dividend in each of the last 3 years.

Net debt stood at Rs 3.2 bn.

Return on equity was 7.6%.

Over the last five years revenue grew at a compound 22.0% a year.

At Rs 362.49 (close on 13 Nov 2026) the shares trade at 16.1× earnings (FY2026) and 1.19× book value, with a dividend yield of 1.5%.

Scorecard vs Pharmaceuticals

14 companies
Growth
Strong
27.9%
Profitability
Below average
5.1%
Financial health
Below average
27.3%
Valuation
Below average
16.1×
Dividends
Average
1.5%

Ratings place the company in its sector: growth (3-year revenue growth), profitability (net margin; return on equity for banks, insurers and finance companies), financial health (debt to equity, industrial companies), valuation (P/E at today's price) and dividends (yield at today's price). Five dots = top fifth. Rated within the sector when at least four companies report the figure, otherwise against all PSX companies of the same type (marked vs PSX). Information, not investment advice.

Corporate

FEROZ announcements & payouts

All FEROZ announcements →
29 Oct 2026 · 11:14
Result · First quarter to 30 Sep 2026
Profit after tax (consolidated)
Rs 395.8 mn
EPS
Rs 7.40 +24.4%
EPS a year earlier
Rs 5.95
29 Oct 2026 · 11:13
Result · First quarter to 30 Sep 2026
Profit after tax (unconsolidated)
Rs 219.6 mn
EPS
Rs 5.05 -15.1%
EPS a year earlier
Rs 5.95
29 Sep 2026 · 15:38
Result · Full year to 30 Jun 2026
Profit after tax (consolidated)
Rs 1,227.7 mn
EPS
Rs 22.51 +26.0%
EPS a year earlier
Rs 17.86
29 Sep 2026 · 15:37
Result · Full year to 30 Jun 2026 Cash 55% · Rs 5.50 · Final AGM 28 Oct
Profit after tax (unconsolidated)
Rs 650.9 mn
EPS
Rs 14.97 -16.2%
EPS a year earlier
Rs 17.86

Book closure 21 Oct – 28 Oct 2026 · Buy by Fri 16 Oct (est.) for the payout

Financial highlights

FEROZ financial results

FEROZ annual financial highlights (Rs bn)
Rs bn FY2026 Jul 2025 – Jun 2026 FY2025 Jul 2024 – Jun 2025 FY2024 Jul 2023 – Jun 2024 FY2023 Jul 2022 – Jun 2023 FY2022 Jul 2021 – Jun 2022 FY2021 Jul 2020 – Jun 2021 FY2020 Jul 2019 – Jun 2020 FY2019 Jul 2018 – Jun 2019 FY2018 Jul 2017 – Jun 2018 FY2017 Jul 2016 – Jun 2017
Revenue 24.0 18.9 15.9 11.5 9.3 8.9 6.2 5.8 5.1 5.0
Gross profit 10.7 8.0 6.5 4.3 4.0 3.7 2.3 2.0 1.6 1.9
Operating profit 2.3 1.9 1.6 0.4 1.0 1.4 0.5 0.3 0.1 0.6
Profit after tax 1.2 0.9 0.8 0.3 0.8 1.3 0.4 0.2 (0.0) 0.4
Profit attributable to shareholders 1.0 0.8 0.7 0.3 0.7 1.2 0.4 0.2 0.0 0.4
EPS – basic (Rs) Rs 22.51 17.86 15.72 6.24 16.90 27.00 9.59 4.62 0.16 9.10
Dividend per share (Rs) Rs 5.50 4.00 3.00 0.00 4.17 8.33 2.78 4.17 1.39 4.86
Total assets 25.9 24.6 21.7 16.6 14.0 12.0 9.0 7.1 7.0 6.8
Total equity 15.6 14.5 11.8 8.4 8.3 7.9 6.6 5.6 5.6 5.7
Total debt 4.3 4.3 4.9 3.6 2.2 1.2 0.2 0.0 0.1 0.0
Net cash from operating activities 0.0 0.9 (1.1) (0.4) 0.5 1.8 0.1 0.4 0.5 0.8
Capital expenditure (1.2) (0.7) (0.6) (2.3) (1.8) (1.2) (0.4) (0.4) (0.4) (0.4)
Free cash flow (operating cash flow − capex) (1.2) 0.2 (1.7) (2.8) (1.3) 0.6 (0.3) 0.0 0.2 0.4
FEROZ quarterly financial highlights (Rs bn)
Rs bn TTM to Jun 2026 Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024
Revenue 24.0 5.8 5.6 6.7 5.9 4.5 5.1 4.7 4.5
Gross profit 10.7 2.5 2.5 3.1 2.6 2.0 2.1 2.1 1.9
Operating profit 2.5 0.6 0.5 0.7 0.6 0.6 0.5 0.5 0.6
Profit after tax 1.2 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2
Profit attributable to shareholders 1.0 0.2 0.2 0.3 0.3 0.2 0.2 0.2 0.2
EPS – basic (Rs) Rs 22.51 5.59 4.78 6.19 5.95 4.74 4.59 3.46 5.07
Dividend per share (Rs) Rs 5.50 5.50 0.00 0.00 0.00 4.00 0.00 0.00 0.00
Total assets 25.9 25.9 26.5 26.8 24.5 24.6 24.4 27.4 24.1
Total equity 15.6 15.6 15.2 15.0 14.8 14.5 14.2 14.0 12.1
Total debt 4.3 4.3 4.9 4.1 3.7 4.3 4.3 7.0 5.0
Net cash from operating activities 0.0 0.2 (1.3) 0.4 0.8 0.5 (0.2) 0.7 (0.0)
Capital expenditure (1.2) (0.3) (0.6) (0.2) (0.1) (0.2) (0.1) (0.3) (0.1)
Free cash flow (operating cash flow − capex) (1.2) (0.1) (1.9) 0.2 0.6 0.3 (0.3) 0.4 (0.2)

Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 17 Oct 2026.

FEROZ charts

Revenue and profit Revenue Profit attributable
Revenue and profit Rs 24 bn Revenue FY17: Rs 5.0 bn Profit attributable FY17: Rs 395.8 mn FY17 Revenue FY18: Rs 5.1 bn Profit attributable FY18: Rs 7.1 mn FY18 Revenue FY19: Rs 5.8 bn Profit attributable FY19: Rs 200.8 mn FY19 Revenue FY20: Rs 6.2 bn Profit attributable FY20: Rs 417.0 mn FY20 Revenue FY21: Rs 8.9 bn Profit attributable FY21: Rs 1.2 bn FY21 Revenue FY22: Rs 9.3 bn Profit attributable FY22: Rs 734.4 mn FY22 Revenue FY23: Rs 11.5 bn Profit attributable FY23: Rs 271.3 mn FY23 Revenue FY24: Rs 15.9 bn Profit attributable FY24: Rs 683.1 mn FY24 Revenue FY25: Rs 18.9 bn Profit attributable FY25: Rs 776.5 mn FY25 Revenue FY26: Rs 24.0 bn Profit attributable FY26: Rs 978.6 mn FY26
Margins Gross margin Operating margin Net margin
Margins 48% 24% 0% Gross margin FY17: 38.2% Gross margin FY18: 31.6% Gross margin FY19: 35.2% Gross margin FY20: 37.4% Gross margin FY21: 41.3% Gross margin FY22: 42.7% Gross margin FY23: 37.2% Gross margin FY24: 40.8% Gross margin FY25: 42.4% Gross margin FY26: 44.7% Operating margin FY17: 11.3% Operating margin FY18: 1.7% Operating margin FY19: 4.6% Operating margin FY20: 8.0% Operating margin FY21: 16.0% Operating margin FY22: 10.7% Operating margin FY23: 3.8% Operating margin FY24: 10.0% Operating margin FY25: 9.9% Operating margin FY26: 9.5% Net margin FY17: 7.9% Net margin FY18: -0.3% Net margin FY19: 3.2% Net margin FY20: 6.8% Net margin FY21: 14.5% Net margin FY22: 8.5% Net margin FY23: 2.6% Net margin FY24: 4.8% Net margin FY25: 4.9% Net margin FY26: 5.1% FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26
Cash flow Operating cash flow Capex Free cash flow
Cash flow Rs 2 bn -Rs 3 bn Operating cash flow FY17: Rs 849.1 mn Capex FY17: -Rs 407.3 mn Free cash flow FY17: Rs 441.9 mn FY17 Operating cash flow FY18: Rs 547.3 mn Capex FY18: -Rs 364.7 mn Free cash flow FY18: Rs 182.6 mn FY18 Operating cash flow FY19: Rs 400.7 mn Capex FY19: -Rs 361.5 mn Free cash flow FY19: Rs 39.2 mn FY19 Operating cash flow FY20: Rs 122.3 mn Capex FY20: -Rs 427.3 mn Free cash flow FY20: -Rs 304.9 mn FY20 Operating cash flow FY21: Rs 1.8 bn Capex FY21: -Rs 1.2 bn Free cash flow FY21: Rs 584.5 mn FY21 Operating cash flow FY22: Rs 458.5 mn Capex FY22: -Rs 1.8 bn Free cash flow FY22: -Rs 1.3 bn FY22 Operating cash flow FY23: -Rs 441.0 mn Capex FY23: -Rs 2.3 bn Free cash flow FY23: -Rs 2.8 bn FY23 Operating cash flow FY24: -Rs 1.1 bn Capex FY24: -Rs 604.5 mn Free cash flow FY24: -Rs 1.7 bn FY24 Operating cash flow FY25: Rs 898.6 mn Capex FY25: -Rs 668.7 mn Free cash flow FY25: Rs 229.9 mn FY25 Operating cash flow FY26: Rs 29.1 mn Capex FY26: -Rs 1.2 bn Free cash flow FY26: -Rs 1.2 bn FY26

Valuation

FEROZ valuation at today's price

Price to earnings (P/E)
16.1×
EPS Rs 22.51 (FY2026)
Price to book (P/B)
1.19×
Book value Rs 304.56 (FY2026)
Dividend yield
1.5%
DPS Rs 5.50 (FY2026)
Earnings yield
6.2%
EPS ÷ price

At the closing price of Rs 362.49 on 13 Nov 2026. P/E and P/B are not shown when earnings or book value are negative.

Sector peers

FEROZ vs Pharmaceuticals companies

Largest companies in the sector at today's prices
Company Market cap P/E P/B Yield ROE 3-yr growth
FEROZ Rs 15.8 bn 16.1× 1.19× 1.5% 7.6% 27.9%
GLAXO Rs 107.1 bn 10.3× 3.11× 5.1% 32.4% 16.3%
ABOT Rs 97.9 bn 11.4× 3.05× 4.0% 28.8% 15.2%
HALEON Rs 81.6 bn 12.4× 5.02× 4.3% 47.6% 16.2%
HINOON Rs 50.8 bn 12.8× 3.95× 5.2% 32.3% 20.5%
AGP Rs 43.8 bn 11.7× 2.92× 5.1% 25.9% 26.0%
HPL Rs 38.5 bn 10.3× 4.50× 6.0% 38.6% 18.6%
CPHL Rs 14.5 bn 18.3× 1.34× 0.0% 7.3% 4.3%
MACTER Rs 12.0 bn 17.7× 2.87× 0.0% 17.4% 20.7%

All Pharmaceuticals companies, medians and leaders →

Analyses & signals 0

Win rate — · 0 closed signals · average return —

No analyses published for FEROZ yet.

FEROZ: frequently asked questions

What is FEROZ's EPS?

Ferozsons Laboratories Limited reported basic earnings per share of Rs 22.51 for FY2026 (Jul 2025 – Jun 2026).

What is FEROZ's P/E ratio?

At the closing price of Rs 362.49 on 13 Nov 2026, FEROZ trades at a P/E of 16.1× based on EPS of Rs 22.51 (FY2026).

Does FEROZ pay dividends?

Yes. Ferozsons Laboratories Limited declared a dividend of Rs 5.50 per share for FY2026. It has paid a dividend in each of the last 3 years. At Rs 362.49 that is a dividend yield of 1.5%.

What was FEROZ's revenue and profit in FY2026?

Ferozsons Laboratories Limited reported revenue of Rs 24.0 bn and profit attributable to shareholders of Rs 978.6 mn for FY2026 (Jul 2025 – Jun 2026).

What is FEROZ's book value per share?

Ferozsons Laboratories Limited's book value per share was Rs 304.56 at the end of FY2026. The shares trade at 1.19× book value.

How has FEROZ's share price performed?

FEROZ's share price is down 3.5% year to date (KSE-100: +2.2%), down 8.7% over one year (KSE-100: +10.7%) and up 15.8% over five years (KSE-100: +288.8%), as of 13 Nov 2026. These are price returns; dividends are not included.

Information only, not investment advice.